Common Stock Warrants

12 Months Ended

Dec. 31, 2021

Common Stock Warrants

Common Stock Warrants

12)    Common Stock Warrants

Upon the consummation of the Merger as disclosed in Note 1, Neurotrope warrants issued and outstanding as of December 1, 2020 were converted into equivalent warrants to purchase common stock of Petros and were adjusted to give effect to the Exchange Ratio set forth in the Merger Agreement. The following is a summary of warrants for the year ended December 31, 2021:

	Number of Shares
Warrants outstanding at December 1, 2020	4,407,962
Warrants issued	—
Warrants exercised	—
Warrants expired	—
Warrants outstanding at December 31, 2020	4,407,962
Warrants issued	7,853,558
Warrants exercised	(2,014,586)
Warrants expired	(207,913)
Warrants outstanding at December 31, 2021	10,039,021

As of December 31, 2021, the Company’s warrants by expiration date were as follows:

Number of Warrants	Exercise Price		Expiration Date
2,780		1.60	August 23, 2023
22,800		35.65	June 1, 2024
74,864		21.85	June 17, 2024
20,043		31.25	June 19, 2024
22,800		26.55	September 1, 2024
10,500		12.738	September 16, 2024
22,800		4.30	December 1, 2024
28,000		5.65	March 2, 2025
28,000		7.30	June 1, 2025
28,000		5.50	September 1, 2025
28,000		4.705	December 1, 2025
2,221,829		7.50	December 1, 2025
908,498		17.50	December 1, 2025
623,303		51.25	December 1, 2025
157,832		125.00	December 1, 2025
1,751,311		1.715	October 18, 2026
2,337,719		3.50	December 12, 2026
1,749,942		3.50	December 27, 2026
10,039,021